Jonathan B. Siegel

Insider Reports History

Entity
Individual
Location
C/O Kingdon Capital Management, L.L.C., 152 West 57 Th Street, 50 Th Floor, New York, NY
Signature
/s/ Lisa A. Conte, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan B. Siegel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jaguar Health, Inc. Director Stock option (right to buy) 26.5K Oct 8, 2024 Direct
Opy Acquisition Corp. I Chief Executive Officer, Director Common Stock 0 Oct 26, 2021 Direct

Insider Reports Filed by Jonathan B. Siegel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JAGX Jaguar Health, Inc. Oct 8, 2024 1 $0 4 Oct 10, 2024 Director
JAGX Jaguar Health, Inc. Aug 14, 2023 1 $0 4 Aug 14, 2023 Director
JAGX Jaguar Health, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
JAGX Jaguar Health, Inc. May 18, 2022 2 $0 4 May 18, 2022 Director
JAGX Jaguar Health, Inc. Mar 28, 2022 1 $0 4 Mar 30, 2022 Director
OHAA Opy Acquisition Corp. I Oct 26, 2021 0 $0 3 Oct 27, 2021 Chief Executive Officer, Director
JAGX Jaguar Health, Inc. May 18, 2021 2 $0 4 May 20, 2021 Director